PAG
BMRN icon

Private Advisor Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Private Advisor Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,320
Closed -$226K – 2027
2023
Q1 		$226K Buy
+2,320
New +$241K ﹤0.01% 1725
2022
Q4 		– Sell
-3,021
Closed -$256K – 1697
2022
Q3 		$256K Buy
3,021
+180
+6% +$16K ﹤0.01% 1557
2022
Q2 		$235K Buy
+2,841
New +$226K ﹤0.01% 1762
2022
Q1 		– Sell
-5,078
Closed -$449K – 2107
2021
Q4 		$449K Buy
5,078
+893
+21% +$73.7K ﹤0.01% 1498
2021
Q3 		$323K Buy
+4,185
New +$330K ﹤0.01% 1687
2021
Q1 		– Sell
-3,520
Closed -$309K – 1900
2020
Q4 		$309K Sell
3,520
-764
-18% -$60.6K ﹤0.01% 1441
2020
Q3 		$326K Buy
4,284
+1,087
+34% +$110K ﹤0.01% 1222
2020
Q2 		$394K Buy
3,197
+104
+3% +$10.3K 0.01% 1104
2020
Q1 		$261K Buy
3,093
+83
+3% +$7.15K ﹤0.01% 1134
2019
Q4 		$254K Sell
3,010
-166
-5% -$12.5K ﹤0.01% 1352
2019
Q3 		$214K Sell
3,176
-1,222
-28% -$94.1K ﹤0.01% 1471
2019
Q2 		$377K Sell
4,398
-853
-16% -$73K 0.01% 1175
2019
Q1 		$467K Buy
5,251
+599
+13% +$55.5K 0.01% 1001
2018
Q4 		$396K Sell
4,652
-502
-10% -$47.8K 0.01% 922
2018
Q3 		$500K Sell
5,154
-6,811
-57% -$680K 0.01% 994
2018
Q2 		$1.13M Buy
+11,965
New +$1.05M 0.02% 442
2017
Q4 		– Sell
-4,111
Closed -$390K – 1200
2017
Q3 		$390K Sell
4,111
-1,098
-21% -$97K 0.01% 1005
2017
Q2 		$468K Sell
5,209
-718
-12% -$65.3K 0.01% 867
2017
Q1 		$511K Buy
5,927
+2,430
+69% +$216K 0.01% 820
2016
Q4 		$300K Buy
3,497
+877
+33% +$75.4K 0.01% 949
2016
Q3 		$249K Buy
2,620
+145
+6% +$13.7K 0.01% 912
2016
Q2 		$200K Buy
+2,475
New +$210K 0.01% 993

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Private Advisor Group's BMRN Position: Q2 2023 in Review

Private Advisor Group sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2023, closing a stake of 2,320 shares — an estimated $226K sold.

Private Advisor Group first reported a position in BMRN in Q2 2016 and held it in 22 quarters. The position peaked at $1.13M in Q2 2018. 558 funds tracked by Wall St. Rank hold BMRN as of Q2 2023.

  • Private Advisor Group reported no remaining BioMarin Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Private Advisor Group sold 2,320 BioMarin Pharmaceuticals shares in Q2 2023, an estimated $226K.
  • Private Advisor Group first reported a position in BioMarin Pharmaceuticals in Q2 2016 and held it in 22 quarters.
  • Private Advisor Group's BioMarin Pharmaceuticals position peaked at $1.13M in Q2 2018.
  • 558 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2023.

Based on Private Advisor Group's 13F filing for Q2 2023, filed 10 Aug 2023.